Kenvue reports FY23 revenue $15.4B (+3.3%); Q4 revenue down 2.7%; guides FY24 adjusted EPS $1.10-1.20

Kenvue Inc.

2023-FY EPS reported $0.90 revenue$15,444,000,000

FY23 net sales $15.4B, +3.3%; organic growth 5.0%; adjusted diluted EPS $1.29.
Q4 net sales $3.7B, -2.7%; organic decline 2.4%; adjusted EPS $0.31.
FY23 diluted EPS $0.90 (GAAP); adjusted $1.29.
FY24 outlook: net sales growth 1-3%, organic 2-4%; adjusted EPS $1.10-$1.20, below FY23.
CEO cites U.S. Skin Health/Beauty weakness; expects sequential improvement in 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Kenvue Inc. reported the fiscal full year and fourth quarter ended December 31, 2023 results: revenue $15.4 billion, EPS $0.90. Guidance initiated.

Period: the fiscal full year and fourth quarter ended December 31, 2023
Revenue: $15.4 billion
EPS: $0.90
Guidance: initiated
Result: reported results

Exact text from the filing

Kenvue Reports Full Year and Fourth Quarter 2023 Results FY'23: Net Sales Increased 3.3% to $15.4 billion with Organic Growth 1 of 5.0% FY'23: Diluted Earnings per Share of $0.90; Adjusted Diluted Earnings per Share 1 of $1.29 Q4'23: Net Sales Decreased (2.7)% to $3.7 billion with Organic Growth 1 of (2.4)% Q4'23: Diluted Earnings per Share of $0.17; Adjusted Diluted Earnings per Share 1 of $0.31

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

Kenvue Inc. filing history →

Source: SEC EDGAR

accession 0001944048-24-000007

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.